Georgios Papanikolaou General Hosp. of Thessaloniki

Thessaloniki 57010

0 studies enrolling now · 3 studies all time

What they study most

Multiple Sclerosis, Primary Progressive, Non-Small Cell Lung Cancer, Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer

Studies at this site

• A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis — Completed
• A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110] — Completed
• A Study of Atezolizumab Compared With Gemcitabine Plus (+) Cisplatin or Carboplatin for PD-L1-Selected Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower111) — Stopped early